We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesOncology Institute Inc

Oncology Institute Inc

Healthcare Medical Care Facilities
PortfolioPortfolio WatchlistWatchlist
Company price
None USD 0.00(0%)
Last update at 2026-11-12T15:37:13.071658Z
Market Cap
35.66M

Momentum Score

…

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.33
Low
2.65
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Publicly available information on Oncology Institute Inc (TOI) is limited and does not clearly describe its operations, products, or financial profile. Because disclosures are sparse, material long-term growth drivers cannot be verified; investors should review company filings and investor presentations for substantiation. Exposure to the oncology sector may appeal if the firm can demonstrate clinical progress, scalable services or commercial traction, but those factors are unconfirmed.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
342.71M
Revenue Per Share
4.63
Gross Profit TTM
52.09M
Debt / Equity
2.10
ROE
-104.45%
Net Debt
86.33M
ROCE
-39.00%
Diluted EPS TTM
-0.73

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 1.90M -11.60M -14.81M -2.64M 4.86M
Net income 1.66M -10.93M -14.32M -4.02M 3.95M
Selling general administrative 119.69M 0.48M 0.31M 29.64M 20.39M
Selling and marketing expenses - - 41.59M - -
Gross profit 52.09M 40.85M 36.88M 29.94M 26.28M
Reconciled depreciation 4.41M 3.34M 3.18M 2.94M 1.10M
Ebit -72.01M -45.86M -8.20M -2.63M 4.86M
Ebitda -67.10M -41.47M -11.29M 0.31M 5.96M
Depreciation and amortization 4.91M 4.39M -3.09M 2.94M 1.10M
Non operating income net other 85.94M -7.33M - - -
Operating income -72.01M -45.86M -8.20M -2.63M 4.79M
Other operating expenses 324.49M 248.86M 195.71M 158.05M 108.37M
Interest expense 4.08M 0.32M 0.35M 0.00M 0.00M
Tax provision -0.24M -0.67M -0.49M 1.38M 0.91M
Net interest income -4.08M -0.32M -0.35M -0.00M -0.00M
Income tax expense 0.25M -0.67M -0.49M 1.38M 0.91M
Total revenue 252.48M 203.00M 187.51M 155.41M 113.16M
Total operating expenses 124.10M 86.71M 45.07M 32.59M 21.49M
Cost of revenue 200.39M 162.16M 150.64M 125.46M 86.88M
Total other income expense net 73.91M 34.26M -6.62M -0.00M 0.07M
Net income from continuing ops 0.15M -8.34M -14.32M -4.02M 3.95M
Net income applicable to common shares 0.07M -8.34M -14.32M -4.02M -1.99M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 219.42M 263.75M 203.44M 65.69M 59.52M
Intangible assets 17.90M 17.96M 18.25M 19.52M 22.00M
Other current assets 4.05M 6.92M 12.07M 2.11M 0.72M
Total liab 162.39M 139.07M 99.28M 37.59M 17.30M
Total stockholder equity 57.02M 124.68M 104.16M 28.10M 42.22M
Other current liab 13.41M 13.84M 13.46M 10.60M 4.70M
Common stock 0.01M 0.01M 0.01M 0.01M -
Capital stock 0.01M 0.01M 0.01M 80.11M 48.14M
Retained earnings -146.15M -61.58M -63.23M -52.31M -6.02M
Other liab - 6.09M 69.48M 2.42M 3.71M
Good will 7.23M 23.41M 26.63M 14.23M 14.08M
Other assets - 0.48M 0.32M 0.12M 0.10M
Cash 33.49M 14.01M 114.30M 6.00M 2.45M
Total current liabilities 34.79M 29.85M 29.80M 28.61M 13.59M
Current deferred revenue 0.55M 1.14M 0.59M - -
Net debt 86.33M 94.17M -114.12M 5.93M -2.45M
Short term debt 6.40M 5.50M 0.18M 5.37M -
Short long term debt - - 0.18M 5.37M -
Short long term debt total 119.81M 108.18M 0.18M 11.93M -
Other stockholder equity 203.17M 186.25M 167.39M 0.29M 0.09M
Property plant equipment - 8.55M 4.19M 2.10M 1.55M
Total current assets 143.49M 130.51M 154.06M 29.72M 21.79M
Long term investments 0.00M 58.35M - - -
Net tangible assets - 83.80M 205.96M -85.75M -42.00M
Short term investments 49.37M 59.80M - - -
Net receivables 42.91M 40.52M 21.24M 17.26M 14.73M
Long term debt 86.83M 80.62M - 6.56M -
Inventory 13.68M 9.26M 6.44M 4.35M 3.89M
Accounts payable 14.43M 9.37M 15.56M 12.64M 8.89M
Accumulated other comprehensive income 0.00M - - - -
Common stock total equity - 0.01M 0.00M - -
Retained earnings total equity - -63.08M -24.04M - -
Non currrent assets other 0.56M 0.37M 0.32M 0.12M 0.10M
Non current assets total 75.92M 133.24M 49.38M 35.97M 37.73M
Capital lease obligations 32.85M 27.56M - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -117.51M -12.15M -8.84M -1.20M 2.49M
Change to liabilities -4.87M 0.05M 3.76M 5.53M 6.07M
Total cashflows from investing activities -131.61M -230.00M -8.84M -1.20M 2.49M
Net borrowings 106.34M -7.25M 12.18M -0.00M -0.00M
Total cash from financing activities 92.21M 154.01M 11.89M -0.00M -8.20M
Change to operating activities 7.54M -12.36M 3.81M 2.99M -4.59M
Net income 1.66M -10.93M -14.32M -4.02M 3.95M
Change in cash -101.16M 109.18M 3.55M 2.41M -0.01M
Begin period cash flow 115.17M 6.00M 2.45M 0.04M 0.05M
End period cash flow 14.01M 115.17M 6.00M 2.45M 0.04M
Total cash from operating activities -61.76M -32.68M 0.51M 3.62M 5.64M
Issuance of capital stock 0.00M 20.00M - - -
Depreciation 4.41M 3.34M 3.18M 2.94M 1.10M
Other cashflows from investing activities -8.58M -230.00M -7.50M -7.50M -7.50M
Dividends paid - - 0.00M - 8.20M
Change to inventory -1.73M -1.84M -0.47M -1.13M -0.30M
Change to account receivables -20.29M -2.19M -6.76M -4.33M -1.39M
Sale purchase of stock -9.00M 231.47M - - -
Other cashflows from financing activities 100.41M 141.26M 12.20M -1.20M 2.49M
Change to netincome -47.20M 7.58M 10.60M 1.25M 0.69M
Capital expenditures 5.53M 3.05M 1.19M 1.20M 0.70M
Change receivables -19.66M -2.99M - - -
Cash flows other operating 5.73M 0.13M - - -
Cash and cash equivalents changes -101.16M 0.89M - - -
Change in working capital -20.50M -14.49M 0.99M 3.45M -0.10M
Stock based compensation 27.68M 24.54M 0.15M 0.09M -
Other non cash items -75.19M -33.90M 11.85M 0.33M -
Free cash flow -67.28M -35.73M -0.69M 2.41M 4.95M

Peer Comparison*

Sector: Healthcare Industry: Medical Care Facilities

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
HCA
HCA Healthcare, Inc.		 1.17
0.23%		 507.21 14.27 13.46 1.21 291.34 1.83 8.99
THC
Tenet Healthcare Corporation		 -1.82
0.62%		 291.15 10.08 12.66 0.96 4.57 1.43 5.80
FSNUY
Fresenius SE & Co KGaA ADR		 0.12
0.84%		 14.84 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc		 -
-%		 5.57 62.50 35.97 0.30 2.32 0.16 3.90

Profile*

Oncology Institute Inc

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

18000 Studebaker Road, Cerritos, CA, United States, 90703

(562) 735-3226

https://theoncologyinstitute.com

800

Name Title Year Born
Mr. Richard Alan Barasch Exec. Chairman 1954
Mr. Bradford D. Hively CEO & Director NA
Dr. Daniel Virnich FACHE, M.B.A., M.D., MBA Pres 1979
Ms. Hilda Agajanian M.B.A. Founder & Chief Growth Officer NA
Dr. Richy Agajanian M.D. Founder & Chief Clinical Officer NA
Mr. Mihir Arunkumar Shah CPA Chief Financial Officer 1978
Dr. Matthew Miller M.B.A., M.D. Chief Operating Officer 1977
Mr. Rakesh Singh M.B.A. Director of Technology NA
Mr. G. Philip Reger Chief Information Officer NA
Mr. Mark Hueppelsheuser Esq. Gen. Counsel NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CJT
CAD 111.15
+12.71%
CLS
CAD 374.20
+8.33%
GRZ
CAD 4.90
+7.46%
CTC-A
CAD 218.05
+6.38%
FEC
CAD 7.42
+5.85%
TF
CAD 4.13
-19.65%
TLO
CAD 5.98
-15.06%
FSZ
CAD 2.45
-14.04%
XNDU
CAD 3.60
-8.86%
ITR
CAD 2.75
-8.50%

Equity Sectors*

  • Basic Materials

    -2.63%

  • Communication Services

    -0.79%

  • Consumer Cyclical

    +0.08%

  • Consumer Defensive

    -0.12%

  • Energy

    +0.52%

  • Financial Services

    -1.15%

  • Healthcare

    -1.74%

  • Industrials

    -0.64%

  • Real Estate

    -0.12%

  • Technology

    -0.51%

  • Utilities

    -0.02%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…